Correction to: AAPS PharmSciTech 21, 115 (2020)
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at https://doi.org/10.1208/s12249-020-01653-9
Rights and permissions
About this article
Cite this article
Tashan, E., Karakucuk, A. & Celebi, N. Correction to: Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation. AAPS PharmSciTech 21, 144 (2020). https://doi.org/10.1208/s12249-020-01703-2
Published:
DOI: https://doi.org/10.1208/s12249-020-01703-2